High levels of uPA and uPAR in tumour tissue (and also in plasma) are associated with poor prognosis of patients with cancers of the breast, head and neck, uterine cervix, bladder, lung, ovary or with soft tissue sarcoma (for a review see Reuning et al, 1998). The gene discussed is PLAU; the disease is cancer.